Ratings and price targets from Brookline analysts, and how many of their targets were reached. Latest call 10 June 2026.
12 Buy, 3 Hold and 0 Sell from 31 October 2025 to 30 October 2026. 3 target raises and 3 cuts.
Targets set above the share price from 2008 to October 2025. Across all firms the figure is 59.2%. How we measure.
| Analyst | Ratings, 12 mo | Price targets | Stocks | Avg upside | Targets met | Last call |
|---|---|---|---|---|---|---|
| Tyler Bussian | Buy 100%Hold 0%Sell 0% | 5 | 2 | +380.4% | 10 Jun 2026 | |
| Leah Rush Cann | Buy 83%Hold 17%Sell 0% | 237 | 37 | +218.8% | 8 Jun 2026 | |
| Kemp Dolliver | Buy 67%Hold 33%Sell 0% | 39 | 20 | +222.6% | 9 Apr 2026 |
Analysts with a call in the past 12 months, latest first. Price targets, upside and targets met are each analyst's full Brookline record, as on AnaChart stock pages, shown from 5 targets. Updated daily.
| Date | Stock | Analyst | Action | Price target | Rating |
|---|---|---|---|---|---|
| 10 Jun 2026 | CRVO | Tyler Bussian | Maintained | $15 | Buy |
| 8 Jun 2026 | KYMR | Leah Rush Cann | Raised | $65 → $97 | Buy |
| 9 Apr 2026 | LNTH | Kemp Dolliver | Cut | $100 → $96 | Buy |
| 9 Mar 2026 | SCYX | Kemp Dolliver | Cut | $32 → $27.36 | Buy |
| 3 Mar 2026 | NTLA | Leah Rush Cann | Raised | $99 → $106 | Buy |
| 23 Feb 2026 | CCCC | Leah Rush Cann | Target set | $0 | Buy |
| 5 Jan 2026 | MRKR | Leah Rush Cann | Raised | $4 → $5.60 | Buy |
| 18 Dec 2025 | VRCA | Kemp Dolliver | Target set | $17 | Hold |
| 29 Sep 2025 | OTLK | Kemp Dolliver | Cut | $10 → $0 | Buy |
| 29 Sep 2025 | OTLK | Kemp Dolliver | Cut | $10 → $0 | Buy |
| 25 Sep 2025 | MNPR | Kemp Dolliver | Raised | $52 → $93 | Buy |
| 25 Sep 2025 | MNPR | Kemp Dolliver | Raised | $52 → $93 | Buy |
| 5 Sep 2025 | IBIO | Kemp Dolliver | Maintained | $1.60 | Buy |
| 5 Sep 2025 | IBIO | Kemp Dolliver | Maintained | $1.60 | Buy |
| 28 Aug 2025 | IMAB | Kumaraguru Raja | Target set | $8 | Buy |
| 28 Aug 2025 | IMAB | Kumaraguru Raja | Target set | $8 | Buy |
| 18 Aug 2025 | DARE | Kemp Dolliver | Target set | $11 | Buy |
| 18 Aug 2025 | DARE | Kemp Dolliver | Target set | $11 | Buy |
| 18 Aug 2025 | DARE | Kemp Dolliver | Target set | $11 | Buy |
| 15 Aug 2025 | FBRX | Kumaraguru Raja | Cut | $100 → $54 | Buy |
| 15 Aug 2025 | FBRX | Kumaraguru Raja | Target set | $54 | Buy |
| 13 Aug 2025 | ICCM | Kemp Dolliver | Target set | $2.77 | Buy |
| 13 Aug 2025 | ICCM | Kemp Dolliver | Cut | $166 → $83.10 | Buy |
| 12 Aug 2025 | INTS | Kumaraguru Raja | Target set | $3 | Hold |
| 10 Jul 2025 | MRNA | Leah Rush Cann | Target set | $198 | Buy |
The most recent target from each analyst on each stock. Updated daily.
Which targets were reached, how fast, and each analyst's Performance Score on every stock they cover.
China RenaissanceTiger SecuritiesFBNDBS BankLifeSci
Brookline analysts issued 15 ratings from 31 October 2025 to 30 October 2026: 12 Buy, 3 Hold and 0 Sell, on 15 stocks.
23.3% of the 129 targets its analysts set above the share price from 2008 to October 2025 were reached within 12 months. For those reached, the median wait was 58 days.
By price targets in the past 12 months: Kemp Dolliver (4), Leah Rush Cann (4), Kumaraguru Raja (2).
Source: AnaChart records of analyst ratings and price targets. 12-month figures run from 31 October 2025 to 30 October 2026. Analysts and latest calls update daily. AnaChart publishes data about analysts' past calls. It is not investment advice.